scispace - formally typeset
L

Lin Wang

Researcher at Eli Lilly and Company

Publications -  4
Citations -  1265

Lin Wang is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Nanoparticle & Nanobiotechnology. The author has an hindex of 3, co-authored 4 publications receiving 1153 citations. Previous affiliations of Lin Wang include University of Florida.

Papers
More filters
Journal ArticleDOI

Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.

TL;DR: Recent developments in the use of nanoparticles as drug delivery systems to treat a wide variety of diseases are reviewed and challenges and future nanotechnology strategies to overcome limitations are introduced.
Journal ArticleDOI

Bionanotechnology based on silica nanoparticles

TL;DR: Uniform core/shell nanoparticles, consisting of a silica layer coating and pigments or magnetite core, using a water‐in‐oil microemulsion method, are developed, highly luminescent and photostable with the size ranging from 5 nm to 400 nm.
Journal ArticleDOI

Dye-doped nanoparticles for bioanalysis

TL;DR: D dye-doped silica nanoparticles (NPs), their synthesis, bioconjugation, and applications in different bioanalysis formats are described and it is envisaged that further development of these NPs will provide a variety of advanced tools for molecular biology, genomics, proteomics, drug discovery, and diagnosis and therapy of infectious disease and cancer.
Journal ArticleDOI

Bionanotechnology Based on Silica Nanoparticles

TL;DR: In this paper, a uniform core/shell nanoparticles, consisting of a silica layer coating and pigments or magnetite core, using a water-in-oil microemulsion method, were developed.